BioCentury
ARTICLE | Financial News

Andera, Canaan lead Grey Wolf £10M A round

February 15, 2019 6:23 PM UTC

Cancer immunotherapy company Grey Wolf Therapeutics closed the second tranche of its total £10 million ($12.9 million) series A round to fund development of its immuno-oncology therapies to increase tumor visibility. The round was led by new investors Andera Partners and Canaan Partners.

The first tranche of £5 million ($6.5 million) closed in April 2018, following a £320,000 ($414,000) seed by Sygnature Discovery Ltd. in January 2018...